Alendronate for seconcary prevention of osteoporotic fractures

Main Editor Ilkka Kunnamo
Language en
Last Update Sep 16, 2018
Published Date Sep 16, 2018
Contact
Disclaimer

Sponsors
Abstract

SOF for Health Benefit Analysis

PICOS
PICO 1.1
P: Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
I: Alendronate 10 mg
C: Control - 3 years baseline denominators
O:

PICO 1.2
P: Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
I: Alendronate 10 mg
C: Control - all years baseline denominators
O: